查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1704588

2025年全球體外診斷酵素市場報告

In Vitro Diagnostics Enzymes Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

由於癌症發病率的上升，體外診斷酶市場預計將經歷顯著成長。癌症是指一組以細胞異常生長分裂為特徵的疾病，對健康組織構成威脅。導致癌症發生率上升的因素包括感染疾病、免疫系統功能障礙和荷爾蒙影響。體外診斷 (IVD) 酶在整體癌症護理範圍內的各種診斷和監測檢測中發揮著重要作用，從早期檢測和診斷到治療方法選擇、監測和個人化醫療。例如，世界衛生組織 (WHO) 預測，到 2050 年，新發生癌症病例將比 2022 年增加 77%，這凸顯了癌症管理對體外診斷酶的需求日益增加。

體外診斷酶市場的主要企業正在投資自體免疫疾病檢測套件等創新產品，以保持其在市場中的地位。這些套件旨在檢測免疫系統錯誤攻擊身體組織的自體免疫疾病。例如，NeoDx Biotech Labs Pvt Ltd. 最近推出了一種用於檢測自體免疫疾病的 IVD套件，該試劑盒結合了免疫測量、分子診斷和抗體檢測方法等先進技術。該套件具有較高的敏感性和特異性，可幫助臨床醫師快速且準確地診斷自體免疫疾病。

2023 年 2 月，SD Biosensors Inc. 和 SJL Partners LLC 以 ​​15.3 億美元收購了 Meridian Biosciences Inc.。此次收購使 SD Biosensors 能夠利用 Meridian 在診斷、免疫學和分子測試材料方面的專業知識，用於一系列應用。美國Meridian Bioscience公司因其在體外診斷酶和相關技術方面的貢獻而聞名。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、感染疾病、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球體外診斷酵素PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球體外診斷酵素市場：成長率分析
  • 全球體外診斷酶市場表現：規模與成長，2019-2024
  • 全球體外診斷酶市場預測：規模與成長，2024-2029，2034F
  • 體外診斷酵素的全球總目標市場（TAM）

第6章市場區隔

  • 全球體外診斷酶市場（按酶類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 蛋白酶
  • 聚合酵素和轉錄酶
  • 核糖核酸酶
  • 其他酵素類型
  • 全球體外診斷酶市場：按疾病類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 感染疾病
  • 糖尿病
  • 腫瘤學
  • 心臟病學
  • 腎臟病學
  • 自體免疫疾病
  • 其他類型的疾病
  • 全球體外診斷酵素市場技術、效能及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 組織學檢測
  • 分子診斷
  • 臨床化學
  • 其他技術
  • 全球體外診斷酵素市場最終用途、效能及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 製藥和生物技術
  • 醫院和診斷實驗室
  • 合約研究組織（CRO）
  • 學術實驗室
  • 全球體外診斷酵素市場蛋白酶細分（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 胰蛋白酶
  • 胃蛋白酶
  • 蛋白酶K
  • 全球體外診斷酶市場聚合酵素和轉錄酶細分市場（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • DNA聚合酵素
  • RNA聚合酵素
  • 逆轉錄酶
  • 全球體外診斷酶市場核糖核酸酶細分市場（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • RNase A
  • RNase H
  • 全球體外診斷酶市場，按其他酶類型細分，按類型、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 脫氫酶
  • 脂肪酶
  • 連接酶

第7章 區域和國家分析

  • 全球體外診斷酵素市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球體外診斷酵素市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 體外診斷酶市場：競爭格局
  • 體外診斷酶市場：公司簡介
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Becton Dickinson and Company
  • Agilent Technologies Inc.
  • Grifols SA
  • Hologic Inc.
  • Illumina Inc.
  • Mindray Medical International Limited
  • PerkinElmer Inc.
  • bioMerieux SA
  • QuidelOrtho Corporation
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • DiaSorin SpA
  • Promega Corporation
  • Randox Laboratories Ltd.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年體外診斷酵素市場：提供新機會的國家
  • 2029年體外診斷酵素市場：細分市場帶來新機會
  • 2029年體外診斷酵素市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r30450

In vitro diagnostics (IVD) enzymes are specialized proteins used in diagnostic tests conducted outside the living organism, typically in a laboratory setting. These enzymes catalyze specific biochemical reactions that help detect, quantify, or monitor the presence of various substances, including pathogens, biomarkers, or other molecules relevant to diagnosing diseases.

The main enzyme types in the in vitro diagnostics enzymes market are proteases, polymerase and transcriptase, ribonuclease, and other enzyme types. Proteases refer to enzymes that catalyze the breakdown of proteins into smaller peptides or amino acids. Various disease types are targeted, including infectious diseases, diabetes, oncology, cardiology, nephrology, autoimmune diseases, and others. These enzymes are utilized in various technologies such as histology assays, molecular diagnostics, clinical chemistry, and others, and are used by end users such as pharmaceutical and biotech companies, hospitals and diagnostic labs, contract research organizations (CROs), and academic labs.

The in vitro diagnostics enzymes market research report is one of a series of new reports from The Business Research Company that provides in vitro diagnostics enzymes market statistics, including in vitro diagnostics enzymes industry global market size, regional shares, competitors with an in vitro diagnostics enzymes market share, detailed in vitro diagnostics enzymes market segments, market trends, and opportunities, and any further data you may need to thrive in the in vitro diagnostics enzymes industry. This in vitro diagnostics enzymes research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The in vitro diagnostics enzymes market size has grown strongly in recent years. It will grow from $2.14 billion in 2024 to $2.32 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to increasing incidence of diseases such as cancer and HIV/AIDS, growing need for diagnostic testing and monitoring of age-related diseases, shifts in lifestyle factors, including diet and physical activity, rise in approval of new diagnostic assays and products by regulatory authorities, and higher healthcare expenditures globally.

The in vitro diagnostics enzymes market size is expected to see strong growth in the next few years. It will grow to $3.17 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing focus on personalized healthcare, growing healthcare infrastructure, rising disposable incomes in emerging markets, rise in collaborations between companies and research institutions, and increasing demand for rapid and convenient diagnostic solutions. Major trends in the forecast period include the adoption of microfluidics technologies, development of novel enzyme substrates and detection methods, use of point-of-care molecular diagnostic platforms integrated enzyme-based amplification techniques, integration of CRISPR-based technologies with enzyme assays, use of liquid biopsy techniques, and utilization of advanced data analytics and bioinformatics tools.

The in vitro diagnostics enzymes market is expected to grow significantly due to the rising prevalence of cancer. Cancer refers to a group of diseases characterized by abnormal cell growth and division, posing a threat to healthy tissues. Factors contributing to the increased prevalence of cancer include infectious agents, immune system dysfunctions, and hormonal influences. In vitro diagnostics (IVD) enzymes play a crucial role in various diagnostic and monitoring assays across the cancer care continuum, from early detection and diagnosis to treatment selection, monitoring, and personalized medicine. For example, the World Health Organization (WHO) projects a 77% increase in new cancer cases by 2050 compared to 2022, highlighting the growing need for in vitro diagnostics enzymes in cancer management.

Leading companies in the in vitro diagnostics enzymes market are investing in innovative products such as autoimmune disorder detection kits to maintain their market position. These kits are designed to detect autoimmune diseases, where the immune system mistakenly attacks the body's tissues. For instance, NeoDx Biotech Labs Pvt Ltd. recently launched an IVD kit for detecting autoimmune disorders, incorporating advanced technologies such as immunoassays, molecular diagnostics, and antibody detection methods. This kit offers high sensitivity and specificity, enabling clinicians to swiftly and accurately diagnose autoimmune conditions.

In February 2023, SD Biosensor Inc. and SJL Partners LLC acquired Meridian Bioscience Inc. for $1.53 billion. This acquisition allows SD Biosensor to leverage Meridian's expertise in diagnostic products and raw materials for immunological and molecular tests across various applications. Meridian Bioscience Inc., based in the US, is known for its contributions to in vitro diagnostic enzymes and related technologies.

Major companies operating in the in vitro diagnostics enzymes market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company, Agilent Technologies Inc., Grifols SA, Hologic Inc., Illumina Inc., Mindray Medical International Limited, PerkinElmer Inc., bioMerieux SA, QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., DiaSorin SpA, Promega Corporation, Randox Laboratories Ltd., Meridian Bioscience Inc., Fujirebio Diagnostics Inc., Sekisui Diagnostics LLC, Trivitron Healthcare, Codexis Inc., Amicogen Inc., EKF Diagnostics Holdings plc, Advanced Enzymes Technologies Ltd., Biocatalysts Ltd., Alpha Laboratories Ltd.

North America was the largest region in the in vitro diagnostics enzymes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro diagnostics enzymes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the in vitro diagnostics enzymes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The in vitro diagnostics (IVD) enzymes market consists of revenues earned by entities by providing services such as enzyme engineering, custom enzyme production, validation services, promega custom assay services, and bio-techne enzyme solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The in vitro diagnostics (IVD) enzymes market also includes sales of Taq DNA polymerase, reverse transcriptase, alkaline phosphatase (ALP), horseradish peroxidase (HRP), DNA ligase, NEB enzyme products, and sigma-Aldrich diagnostic enzymes. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In Vitro Diagnostics Enzymes Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in vitro diagnostics enzymes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in vitro diagnostics enzymes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The in vitro diagnostics enzymes market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Enzyme Type: Proteases; Polymerase And Transcriptase; Ribonuclease; Other Enzyme Types
  • 2) By Disease Type: Infectious Disease; Diabetes; Oncology; Cardiology; Nephrology; Autoimmune Diseases; Other Disease Types
  • 3) By Technology: Histology Assays; Molecular Diagnostics; Clinical Chemistry; Other Technologies
  • 4) By End Use: Pharma And Biotech; Hospital And Diagnostic Labs; Contract Research Organizations (CROs); Academic Labs
  • Subsegments:
  • 1) By Proteases: Trypsin; Pepsin; Proteinase K
  • 2) By Polymerase And Transcriptase: DNA Polymerase; RNA Polymerase; Reverse Transcriptase
  • 3) By Ribonuclease: RNase A; RNase H
  • 4) By Other Enzyme Types: Dehydrogenases; Lipases; Ligases
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Siemens Healthineers AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. In Vitro Diagnostics Enzymes Market Characteristics

3. In Vitro Diagnostics Enzymes Market Trends And Strategies

4. In Vitro Diagnostics Enzymes Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global In Vitro Diagnostics Enzymes Growth Analysis And Strategic Analysis Framework

  • 5.1. Global In Vitro Diagnostics Enzymes PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global In Vitro Diagnostics Enzymes Market Growth Rate Analysis
  • 5.4. Global In Vitro Diagnostics Enzymes Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global In Vitro Diagnostics Enzymes Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global In Vitro Diagnostics Enzymes Total Addressable Market (TAM)

6. In Vitro Diagnostics Enzymes Market Segmentation

  • 6.1. Global In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Proteases
  • Polymerase And Transcriptase
  • Ribonuclease
  • Other Enzyme Types
  • 6.2. Global In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Infectious Disease
  • Diabetes
  • Oncology
  • Cardiology
  • Nephrology
  • Autoimmune Diseases
  • Other Disease Types
  • 6.3. Global In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Histology Assays
  • Molecular Diagnostics
  • Clinical Chemistry
  • Other Technologies
  • 6.4. Global In Vitro Diagnostics Enzymes Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharma And Biotech
  • Hospital And Diagnostic Labs
  • Contract Research Organizations (CROs)
  • Academic Labs
  • 6.5. Global In Vitro Diagnostics Enzymes Market, Sub-Segmentation Of Proteases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Trypsin
  • Pepsin
  • Proteinase K
  • 6.6. Global In Vitro Diagnostics Enzymes Market, Sub-Segmentation Of Polymerase And Transcriptase, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • DNA Polymerase
  • RNA Polymerase
  • Reverse Transcriptase
  • 6.7. Global In Vitro Diagnostics Enzymes Market, Sub-Segmentation Of Ribonuclease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • RNase A
  • RNase H
  • 6.8. Global In Vitro Diagnostics Enzymes Market, Sub-Segmentation Of Other Enzyme Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dehydrogenases
  • Lipases
  • Ligases

7. In Vitro Diagnostics Enzymes Market Regional And Country Analysis

  • 7.1. Global In Vitro Diagnostics Enzymes Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global In Vitro Diagnostics Enzymes Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific In Vitro Diagnostics Enzymes Market

  • 8.1. Asia-Pacific In Vitro Diagnostics Enzymes Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China In Vitro Diagnostics Enzymes Market

  • 9.1. China In Vitro Diagnostics Enzymes Market Overview
  • 9.2. China In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India In Vitro Diagnostics Enzymes Market

  • 10.1. India In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan In Vitro Diagnostics Enzymes Market

  • 11.1. Japan In Vitro Diagnostics Enzymes Market Overview
  • 11.2. Japan In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia In Vitro Diagnostics Enzymes Market

  • 12.1. Australia In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia In Vitro Diagnostics Enzymes Market

  • 13.1. Indonesia In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea In Vitro Diagnostics Enzymes Market

  • 14.1. South Korea In Vitro Diagnostics Enzymes Market Overview
  • 14.2. South Korea In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe In Vitro Diagnostics Enzymes Market

  • 15.1. Western Europe In Vitro Diagnostics Enzymes Market Overview
  • 15.2. Western Europe In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK In Vitro Diagnostics Enzymes Market

  • 16.1. UK In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany In Vitro Diagnostics Enzymes Market

  • 17.1. Germany In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France In Vitro Diagnostics Enzymes Market

  • 18.1. France In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy In Vitro Diagnostics Enzymes Market

  • 19.1. Italy In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain In Vitro Diagnostics Enzymes Market

  • 20.1. Spain In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe In Vitro Diagnostics Enzymes Market

  • 21.1. Eastern Europe In Vitro Diagnostics Enzymes Market Overview
  • 21.2. Eastern Europe In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia In Vitro Diagnostics Enzymes Market

  • 22.1. Russia In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America In Vitro Diagnostics Enzymes Market

  • 23.1. North America In Vitro Diagnostics Enzymes Market Overview
  • 23.2. North America In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA In Vitro Diagnostics Enzymes Market

  • 24.1. USA In Vitro Diagnostics Enzymes Market Overview
  • 24.2. USA In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada In Vitro Diagnostics Enzymes Market

  • 25.1. Canada In Vitro Diagnostics Enzymes Market Overview
  • 25.2. Canada In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America In Vitro Diagnostics Enzymes Market

  • 26.1. South America In Vitro Diagnostics Enzymes Market Overview
  • 26.2. South America In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil In Vitro Diagnostics Enzymes Market

  • 27.1. Brazil In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East In Vitro Diagnostics Enzymes Market

  • 28.1. Middle East In Vitro Diagnostics Enzymes Market Overview
  • 28.2. Middle East In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa In Vitro Diagnostics Enzymes Market

  • 29.1. Africa In Vitro Diagnostics Enzymes Market Overview
  • 29.2. Africa In Vitro Diagnostics Enzymes Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa In Vitro Diagnostics Enzymes Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa In Vitro Diagnostics Enzymes Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. In Vitro Diagnostics Enzymes Market Competitive Landscape And Company Profiles

  • 30.1. In Vitro Diagnostics Enzymes Market Competitive Landscape
  • 30.2. In Vitro Diagnostics Enzymes Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. In Vitro Diagnostics Enzymes Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson and Company
  • 31.2. Agilent Technologies Inc.
  • 31.3. Grifols SA
  • 31.4. Hologic Inc.
  • 31.5. Illumina Inc.
  • 31.6. Mindray Medical International Limited
  • 31.7. PerkinElmer Inc.
  • 31.8. bioMerieux SA
  • 31.9. QuidelOrtho Corporation
  • 31.10. Sysmex Corporation
  • 31.11. Bio-Rad Laboratories Inc.
  • 31.12. Qiagen N.V.
  • 31.13. DiaSorin SpA
  • 31.14. Promega Corporation
  • 31.15. Randox Laboratories Ltd.

32. Global In Vitro Diagnostics Enzymes Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The In Vitro Diagnostics Enzymes Market

34. Recent Developments In The In Vitro Diagnostics Enzymes Market

35. In Vitro Diagnostics Enzymes Market High Potential Countries, Segments and Strategies

  • 35.1 In Vitro Diagnostics Enzymes Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 In Vitro Diagnostics Enzymes Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 In Vitro Diagnostics Enzymes Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer